ICJIM

The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Index
Review
General approach to hemoptysis
Hemoptysis is bleeding from the mouth originating from the lungs or bronchi. It is one of the most important symptoms in chest diseases that leads to urgent admission and requires urgent intervention. Massive hemoptysis is defined as any life-threatening bleeding. Although an expected blood volume of more than 600 ml in 24 hours is often defined as massive hemoptysis, there is no universally accepted specific volume amount. Correct diagnosis and treatment is required in every patient presenting with hemoptysis.


1. Karlafti E, Tsavdaris D, Kotzakioulafi E, et al. Which is the best way to treat massive hemoptysis? A systematic review and meta-analysis of observational studies. J Pers Med. 2023;13(12):1649. doi:10.3390/jpm13121649
2. O’Gurek D, Choi HYJ. Hemoptysis: evaluation and management. Am Fam Physician. 2022;105(2):144-151.
3. Earwood JS, Thompson TD. Hemoptysis: evaluation and management. Am Fam Physician. 2015;91(4):243-249.
4. Chandler JK, Reid MM, Pitts L, Jasahui MRP. Evaluation & management of clinically significant hemoptysis-a clinical practice review. AME Med J. 2024;9:1. doi: 10.21037/amj-23-99
5. Kathuria H, Hollingsworth HM, Vilvendhan R, Reardon C. Management of life-threatening hemoptysis. J Intensive Care. 2020;23(8):1-9. doi:10.1186/s40560-020-00441-8
6. Charya AV, Holden VK, Pickering EM. Management of life-threatening hemoptysis in the ICU. J Thorac Dis. 2021;13(8):5139-5158.
7. Dumanlı A, Aydın S. Hemoptizi şikâyetiyle başvuran hastaların değerlendirilmesi. Kocatepe Tıp Derg. 2022;23(3):344-349. doi: 10.18229/kocatepetip.977399
8. Karmakar S, Sharma P, Harishkumar A, Yadav R, Kumar M, Rai DK. Approach to hemoptysis: a review. Amrita J Med. 2021;17(3):81-85. doi: 10.4103/AMJM.AMJM_35_21
9. Olsen KM, Manouchehr-Pour S, Donnelly EF, et al. Expert panel on thoracic imaging. ACR appropriateness criteria hemoptysis. J Am Coll Radiol. 2020;17(5):148-159. doi:10.1016/j.jacr.2020.01.043
10. Laitupa AA, Ariawan WP, Maranatha D, Prasenohadi RM. Respiratory failure in massive tuberculosis hemoptysis. Int J Pharm Res. 2020;12(1):2173. doi:10.31838/ijpr/2020.12.01.340
11. Mpika GSM, Kechnaoui S, Tourane LOEI, Fikri O, Amro L. Hemoptysis: epidemiological, clinical and etiological aspects. SAS J Med. 2023;9(11):1139-1143. doi:10.36347/sasjm.2023.v09i11.001
12. Singer ED, Faiz SA, Qdaisat A, et al. Hemoptysis in cancer patients. Cancers (Basel). 2023;15(19):4765. doi:10.3390/cancers15194765
13. Ingbar C. Update diagnosis and treatment of hemoptysis. Sriwijaya J Int Med. 2023;1(2):26-29. doi:10.59345/sjim.v1i2.74
14. Balcı A, Çilekar Ş, Çoşğun İG. Kliniğimize hemoptizi şikâyetiyle başvuran hastalarda hemoptizi etyolojileri ve tedavi yaklaşımları. Kocatepe Tıp Derg. 2021;22(3):197-201. doi:10.18229/kocatepetip.702028
15. Çolak M, Aslaner MA. Hemoptizi yakınması ile başvuran hastalarda etyolojik değerlendirme. Sakarya Tıp Derg. 2019;9(4):626-631. doi: 10.31832/smj.563499
16. Lim RK, Tremblay A, Lu S, Somayaji R. Evaluating hemoptysis hospitalizations among patients with bronchiectasis in the United States: a population-based cohort study. BMC Pulm Med. 2021;21(1):392.
17. Lasake IB, Nawi RIBM, Marzuki NBM. Recurrent haemoptysis in non-small cell lung cancer patient. ILKKM J Med Health Sci. 2020;2(1):19-22.
18. Taşbakan MS. Diffüz alveoler hemoraji. Ege Tıp Derg. 2021;60(1):53-55.
19. Rao Ashwin, Rao R. Catamenial hemoptysis managed with medroxyprogesterone acetate: a management dilemma. Int J Women’s Health Reproduc Sci. 2021;9(2):153-155. doi:10.15296/ijwhr.2021.27
20. Sharma MV, Walikar BA. Recurrent hemoptysis in a patient with bronchial asthma. J Adv Lung Health. 2021;1(2):70-74.
21. Mahendra M, Rashmitha MT, Patil S. A rare cause of hemoptysis in a chronic obstructive pulmonary disease patient. APIK J Int Med. 2022:1-3. doi:10.4103/ajim.ajim_131_22
22. Ittrich H, Bockhorn M, Klose H, Simon M. The diagnosis and treatment of hemoptysis. Dtsch Arztebl Int. 2017;114(21):371-381. doi: 10.3238/arztebl.2017.0371
23. Metin B, Yıldırım Ş, İntepe YS, Erkoç MF. Hemoptizi ve genel yaklaşım. Bull Thorac Surg. 2014;5(4):198-204. doi:10.5152/tcb.2014.031
24. Marquis KM, Raptis CA, Rajput MZ, et al. CT for evaluation of hemoptysis. Radiographics. 2021;41(3):742-761.
25. Gümüştaş S, Çiftçi E. Hemoptizi tanı ve tedavisinde radyolojinin yeri. Bull Thorac Surg. 2014;5(4):214-219. doi:10.5152/tcb.2014.034
26. Choi J, Baik JH, Kim CH, et al. Long-term outcomes and prognostic factors in patients with mild hemoptysis. Am J Emerg Med. 2018;36(7): 1160-1165. doi:10.1016/j.ajem.2017.11.053
27. Cordovilla R, Bollo de Miguel E, Nuñez Ares A, Cosano Povedano FJ, Herráez Ortega I, Jiménez Merchán R. Diagnosis and treatment of hemoptysis. Arch Bronconeumol. 2016;52(7):368-377. doi:10.1016/j.arbres.2015.12.002
28. Gagnon S, Quigley N, Dutau H, Delage A, Fortin M. Approach to hemoptysis in the modern ERA. Can Respir J. 2017;2017:1565030. doi: 10.1155/2017/1565030
29. Nas ÖF, Öngen G, Hacıkurt K, et al. Utilization of different agents in selective embolization of emergency arterial bleeding. Şişli Etfal Hasta Tıp Bül. 2016;50(4):280-286. doi: 10.5350/SEMB.20160826024837
30. Abid N, Loukil M, Mokni A, Badri I, Bouzaidi K, Ghrairi H. Outcomes of bronchial artery embolization for the management of hemoptysis. Tunis Med. 2021;99(2):264-268.
31. Larici AR, Franchi P, Occhipinti M, et al. Diagnosis and management of hemoptysis. Diagn Interv Radiol. 2014;20(4):299-309.
Volume 2, Issue 3, 2024
Page : 68-73
_Footer